Global Competent Cells Market Research Report 2023(Status and Outlook)

Global Competent Cells Market Research Report 2023(Status and Outlook)



Report Overview

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to ""shock"" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.

The Global Competent Cells Market Size was estimated at USD 1989.00 million in 2022 and is projected to reach USD 3754.34 million by 2029, exhibiting a CAGR of 9.50% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Competent Cells market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Competent Cells Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Competent Cells market in any manner.

Global Competent Cells Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck KGaA

Thermo Fisher Scientific

Agilent Technologies

Takara Bio

Promega Corporation

Beijing TransGen Biotech

GeneScript Corporation

Yeastern Biotech

New England Biolabs

QIAGEN N.V.

OriGene Technologies

Lucigen

Zymo Research

Bio-Rad Laboratories

Bioline

Delphi Genetics

IBA GmBH

Cell Applications

BioDynamics Laboratory

Scarab Genomics

GCC Biotech

SMOBIO Technology

Edge BioSystems

Market Segmentation (by Type)

Chemically Competent Cells

Electrocompetent Cells

Market Segmentation (by Application)

Hospitals and Clinics

Diagnostic Centers

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Competent Cells Market

Overview of the regional outlook of the Competent Cells Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Competent Cells
1.2 Key Market Segments
1.2.1 Competent Cells Segment by Type
1.2.2 Competent Cells Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Competent Cells Market Overview
2.1 Global Market Overview
2.1.1 Global Competent Cells Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Competent Cells Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Competent Cells Market Competitive Landscape
3.1 Global Competent Cells Sales by Manufacturers (2018-2023)
3.2 Global Competent Cells Revenue Market Share by Manufacturers (2018-2023)
3.3 Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Competent Cells Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Competent Cells Sales Sites, Area Served, Product Type
3.6 Competent Cells Market Competitive Situation and Trends
3.6.1 Competent Cells Market Concentration Rate
3.6.2 Global 5 and 10 Largest Competent Cells Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Competent Cells Industry Chain Analysis
4.1 Competent Cells Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Competent Cells Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Competent Cells Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Competent Cells Sales Market Share by Type (2018-2023)
6.3 Global Competent Cells Market Size Market Share by Type (2018-2023)
6.4 Global Competent Cells Price by Type (2018-2023)
7 Competent Cells Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Competent Cells Market Sales by Application (2018-2023)
7.3 Global Competent Cells Market Size (M USD) by Application (2018-2023)
7.4 Global Competent Cells Sales Growth Rate by Application (2018-2023)
8 Competent Cells Market Segmentation by Region
8.1 Global Competent Cells Sales by Region
8.1.1 Global Competent Cells Sales by Region
8.1.2 Global Competent Cells Sales Market Share by Region
8.2 North America
8.2.1 North America Competent Cells Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Competent Cells Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Competent Cells Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Competent Cells Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Competent Cells Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck KGaA
9.1.1 Merck KGaA Competent Cells Basic Information
9.1.2 Merck KGaA Competent Cells Product Overview
9.1.3 Merck KGaA Competent Cells Product Market Performance
9.1.4 Merck KGaA Business Overview
9.1.5 Merck KGaA Competent Cells SWOT Analysis
9.1.6 Merck KGaA Recent Developments
9.2 Thermo Fisher Scientific
9.2.1 Thermo Fisher Scientific Competent Cells Basic Information
9.2.2 Thermo Fisher Scientific Competent Cells Product Overview
9.2.3 Thermo Fisher Scientific Competent Cells Product Market Performance
9.2.4 Thermo Fisher Scientific Business Overview
9.2.5 Thermo Fisher Scientific Competent Cells SWOT Analysis
9.2.6 Thermo Fisher Scientific Recent Developments
9.3 Agilent Technologies
9.3.1 Agilent Technologies Competent Cells Basic Information
9.3.2 Agilent Technologies Competent Cells Product Overview
9.3.3 Agilent Technologies Competent Cells Product Market Performance
9.3.4 Agilent Technologies Business Overview
9.3.5 Agilent Technologies Competent Cells SWOT Analysis
9.3.6 Agilent Technologies Recent Developments
9.4 Takara Bio
9.4.1 Takara Bio Competent Cells Basic Information
9.4.2 Takara Bio Competent Cells Product Overview
9.4.3 Takara Bio Competent Cells Product Market Performance
9.4.4 Takara Bio Business Overview
9.4.5 Takara Bio Competent Cells SWOT Analysis
9.4.6 Takara Bio Recent Developments
9.5 Promega Corporation
9.5.1 Promega Corporation Competent Cells Basic Information
9.5.2 Promega Corporation Competent Cells Product Overview
9.5.3 Promega Corporation Competent Cells Product Market Performance
9.5.4 Promega Corporation Business Overview
9.5.5 Promega Corporation Competent Cells SWOT Analysis
9.5.6 Promega Corporation Recent Developments
9.6 Beijing TransGen Biotech
9.6.1 Beijing TransGen Biotech Competent Cells Basic Information
9.6.2 Beijing TransGen Biotech Competent Cells Product Overview
9.6.3 Beijing TransGen Biotech Competent Cells Product Market Performance
9.6.4 Beijing TransGen Biotech Business Overview
9.6.5 Beijing TransGen Biotech Recent Developments
9.7 GeneScript Corporation
9.7.1 GeneScript Corporation Competent Cells Basic Information
9.7.2 GeneScript Corporation Competent Cells Product Overview
9.7.3 GeneScript Corporation Competent Cells Product Market Performance
9.7.4 GeneScript Corporation Business Overview
9.7.5 GeneScript Corporation Recent Developments
9.8 Yeastern Biotech
9.8.1 Yeastern Biotech Competent Cells Basic Information
9.8.2 Yeastern Biotech Competent Cells Product Overview
9.8.3 Yeastern Biotech Competent Cells Product Market Performance
9.8.4 Yeastern Biotech Business Overview
9.8.5 Yeastern Biotech Recent Developments
9.9 New England Biolabs
9.9.1 New England Biolabs Competent Cells Basic Information
9.9.2 New England Biolabs Competent Cells Product Overview
9.9.3 New England Biolabs Competent Cells Product Market Performance
9.9.4 New England Biolabs Business Overview
9.9.5 New England Biolabs Recent Developments
9.10 QIAGEN N.V.
9.10.1 QIAGEN N.V. Competent Cells Basic Information
9.10.2 QIAGEN N.V. Competent Cells Product Overview
9.10.3 QIAGEN N.V. Competent Cells Product Market Performance
9.10.4 QIAGEN N.V. Business Overview
9.10.5 QIAGEN N.V. Recent Developments
9.11 OriGene Technologies
9.11.1 OriGene Technologies Competent Cells Basic Information
9.11.2 OriGene Technologies Competent Cells Product Overview
9.11.3 OriGene Technologies Competent Cells Product Market Performance
9.11.4 OriGene Technologies Business Overview
9.11.5 OriGene Technologies Recent Developments
9.12 Lucigen
9.12.1 Lucigen Competent Cells Basic Information
9.12.2 Lucigen Competent Cells Product Overview
9.12.3 Lucigen Competent Cells Product Market Performance
9.12.4 Lucigen Business Overview
9.12.5 Lucigen Recent Developments
9.13 Zymo Research
9.13.1 Zymo Research Competent Cells Basic Information
9.13.2 Zymo Research Competent Cells Product Overview
9.13.3 Zymo Research Competent Cells Product Market Performance
9.13.4 Zymo Research Business Overview
9.13.5 Zymo Research Recent Developments
9.14 Bio-Rad Laboratories
9.14.1 Bio-Rad Laboratories Competent Cells Basic Information
9.14.2 Bio-Rad Laboratories Competent Cells Product Overview
9.14.3 Bio-Rad Laboratories Competent Cells Product Market Performance
9.14.4 Bio-Rad Laboratories Business Overview
9.14.5 Bio-Rad Laboratories Recent Developments
9.15 Bioline
9.15.1 Bioline Competent Cells Basic Information
9.15.2 Bioline Competent Cells Product Overview
9.15.3 Bioline Competent Cells Product Market Performance
9.15.4 Bioline Business Overview
9.15.5 Bioline Recent Developments
9.16 Delphi Genetics
9.16.1 Delphi Genetics Competent Cells Basic Information
9.16.2 Delphi Genetics Competent Cells Product Overview
9.16.3 Delphi Genetics Competent Cells Product Market Performance
9.16.4 Delphi Genetics Business Overview
9.16.5 Delphi Genetics Recent Developments
9.17 IBA GmBH
9.17.1 IBA GmBH Competent Cells Basic Information
9.17.2 IBA GmBH Competent Cells Product Overview
9.17.3 IBA GmBH Competent Cells Product Market Performance
9.17.4 IBA GmBH Business Overview
9.17.5 IBA GmBH Recent Developments
9.18 Cell Applications
9.18.1 Cell Applications Competent Cells Basic Information
9.18.2 Cell Applications Competent Cells Product Overview
9.18.3 Cell Applications Competent Cells Product Market Performance
9.18.4 Cell Applications Business Overview
9.18.5 Cell Applications Recent Developments
9.19 BioDynamics Laboratory
9.19.1 BioDynamics Laboratory Competent Cells Basic Information
9.19.2 BioDynamics Laboratory Competent Cells Product Overview
9.19.3 BioDynamics Laboratory Competent Cells Product Market Performance
9.19.4 BioDynamics Laboratory Business Overview
9.19.5 BioDynamics Laboratory Recent Developments
9.20 Scarab Genomics
9.20.1 Scarab Genomics Competent Cells Basic Information
9.20.2 Scarab Genomics Competent Cells Product Overview
9.20.3 Scarab Genomics Competent Cells Product Market Performance
9.20.4 Scarab Genomics Business Overview
9.20.5 Scarab Genomics Recent Developments
9.21 GCC Biotech
9.21.1 GCC Biotech Competent Cells Basic Information
9.21.2 GCC Biotech Competent Cells Product Overview
9.21.3 GCC Biotech Competent Cells Product Market Performance
9.21.4 GCC Biotech Business Overview
9.21.5 GCC Biotech Recent Developments
9.22 SMOBIO Technology
9.22.1 SMOBIO Technology Competent Cells Basic Information
9.22.2 SMOBIO Technology Competent Cells Product Overview
9.22.3 SMOBIO Technology Competent Cells Product Market Performance
9.22.4 SMOBIO Technology Business Overview
9.22.5 SMOBIO Technology Recent Developments
9.23 Edge BioSystems
9.23.1 Edge BioSystems Competent Cells Basic Information
9.23.2 Edge BioSystems Competent Cells Product Overview
9.23.3 Edge BioSystems Competent Cells Product Market Performance
9.23.4 Edge BioSystems Business Overview
9.23.5 Edge BioSystems Recent Developments
10 Competent Cells Market Forecast by Region
10.1 Global Competent Cells Market Size Forecast
10.2 Global Competent Cells Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Competent Cells Market Size Forecast by Country
10.2.3 Asia Pacific Competent Cells Market Size Forecast by Region
10.2.4 South America Competent Cells Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Competent Cells by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Competent Cells Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Competent Cells by Type (2024-2029)
11.1.2 Global Competent Cells Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Competent Cells by Type (2024-2029)
11.2 Global Competent Cells Market Forecast by Application (2024-2029)
11.2.1 Global Competent Cells Sales (K Units) Forecast by Application
11.2.2 Global Competent Cells Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings